findmyKOL
Clinical trialNCT04964518UnknownPhase 1/PHASE2Interventional

A Study of APG-2575 in Combination With Azacitidine in Patients With Acute Myeloid Leukemia (AML)

SponsorAscentage Pharma Group Inc.Enrollment24AML, Adult
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Australia
  • Pindara Private Hospital

    Benowa, Queensland, Australia

    Hanlon Sia, MD
    Recruiting
  • Sunshine Coast University Hospital

    Birtinya, Queensland, Australia

    Joshua Richmond, MD
    Recruiting
  • the Northern Hospital

    Epping, Victoria, Australia

    Chong C Chua, MD
    Recruiting
  • Royal Perth Hospital

    Perth, Western Aus, Australia

    Michael Leahy, MD
    Recruiting
United States
  • Ucla Medical Cetner Division of Hematology

    Los Angeles, California, United States

    Caspian Oliai, MD
    Recruiting
  • Novant Health

    Charlotte, North Carolina, United States

    Patricia Kropf, MD
    Recruiting
  • Novant Health

    Winston-Salem, North Carolina, United States

    James Dugan, MD
    Recruiting
  • Mdacc

    Houston, Texas, United States

    Tapan Kadia, MD
    Recruiting
  • Swedish Medical Center

    Seattle, Washington, United States

    Daniel Egan, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

APG 2575 ramp up arm
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Jul 2021
Primary completion
30 Jul 2024
Completion
30 Oct 2024
Last update posted
25 Oct 2023
Registered enrollment
24
Registry id
NCT04964518

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.